Status and phase
Conditions
Treatments
About
The purpose of this study is to explore whether administration of preservative free artificial tears will decrease the level of detectable radioiodine in the tears and nasolacrimal duct system of patients undergoing radioiodine therapy for thyroid carcinoma and thus decrease the risk of developing radioactive iodine associated nasolacrimal duct obstruction.
Full description
Primary Objective:
Secondary Objective:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Use of eye drops, other than artificial tears
History of periocular trauma with tear duct involvement/lacrimal gland trauma
History of lacrimal drainage disease: canaliculitis, dacryocystitis
Prior radiotherapy
Current or prior use of chemotherapy drugs (i.e. 5-fluorouracil, docetaxel)
Medical conditions that predispose to NLD stenosis
Primary purpose
Allocation
Interventional model
Masking
9 participants in 1 patient group
Loading...
Central trial contact
Vanderbilt-Ingram Service for Timely Access
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal